This document summarizes mid-sized hospital information systems (HIS) vendors with annual revenues in the hundreds of millions of dollars. It discusses Meditech, NTT Data Medhost, and HMS/Medhost. For each vendor, it provides details on products, client base, revenue history, acquisitions, and future prospects. It also discusses a major acquisition involving NTT Data and the impact on its consulting business.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...Kumar Satyam
According to the TechSci Research report titled “India Diagnostic Labs Market Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2019-2029,” the India Diagnostic Labs Market was valued at USD 16,471.21 million in 2023 and is projected to grow at an impressive compound annual growth rate (CAGR) of 11.55% through 2029. This significant growth can be attributed to various factors, including collaborations and partnerships among leading companies, the expansion of diagnostic chains, and increasing accessibility to diagnostic services across the country. This comprehensive report delves into the market dynamics, recent trends, drivers, competitive landscape, and benefits of the research report, providing a detailed analysis of the India Diagnostic Labs Market.
Collaborations and Partnerships
Collaborations and partnerships among leading companies play a pivotal role in driving the growth of the India Diagnostic Labs Market. These strategic alliances allow companies to merge their expertise, strengthen their market positions, and offer innovative solutions. By combining resources, companies can enhance their research and development capabilities, expand their product portfolios, and improve their distribution networks. These collaborations also facilitate the sharing of technological advancements and best practices, contributing to the overall growth of the market.
Expansion of Diagnostic Chains
The expansion of diagnostic chains is a driving force behind the growing demand for diagnostic lab services. Diagnostic chains often establish multiple laboratories and diagnostic centers in various cities and regions, including urban and rural areas. This expanded network makes diagnostic services more accessible to a larger portion of the population, addressing healthcare disparities and reaching underserved populations. The presence of diagnostic chain facilities in multiple locations within a city or region provides convenience for patients, reducing travel time and effort. A broader network of labs often leads to reduced waiting times for appointments and sample collection, ensuring that patients receive timely and efficient diagnostic services.
Rising Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases is a significant driver for the demand for diagnostic lab services. Chronic conditions such as diabetes, cardiovascular diseases, and cancer require regular monitoring and diagnostic testing for effective management. The rise in chronic diseases necessitates the use of advanced diagnostic tools and technologies, driving the growth of the diagnostic labs market. Additionally, early diagnosis and timely intervention are crucial for managing chronic diseases, further boosting the demand for diagnostic lab services.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
COVID-19 PCR tests remain a critical component of safe and responsible travel in 2024. They ensure compliance with international travel regulations, help detect and control the spread of new variants, protect vulnerable populations, and provide peace of mind. As we continue to navigate the complexities of global travel during the pandemic, PCR testing stands as a key measure to keep everyone safe and healthy. Whether you are planning a business trip, a family vacation, or an international adventure, incorporating PCR testing into your travel plans is a prudent and necessary step. Visit us at https://www.globaltravelclinics.com/
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
For those battling kidney disease and exploring treatment options, understanding when to consider a kidney transplant is crucial. This guide aims to provide valuable insights into the circumstances under which a kidney transplant at the renowned Hiranandani Hospital may be the most appropriate course of action. By addressing the key indicators and factors involved, we hope to empower patients and their families to make informed decisions about their kidney care journey.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
2. Mid-Range Vendors
• After the intro summed up the market, these episodes delve into
the details of 3 vendor niches of the HIS market, this week:
– Mid-Range = community hospitals of 100-300 beds in size
• Interesting how the size of the annual revenue of our 3 vendor
groupings corresponds to the bed size of their target market…
• This episode covers these mid-sized vendors’
- Annual revenue: both for 2015 and their
20-year HIS-tory, “only” in the hundreds
of millions, rather than billions of $s
- Product lines and client base by bed size
- M & As and other recent developments
- Candid assessment of future prospects
3. • Ranked # 5 in terms of 2015 revenue is Medical Information
Technology, 46 years after their humble beginnings in 1969. They
weren’t really much of a hospital player until the mid ‘70s
starting with an LIS, gradually expanded to a full HIS in the ‘80s.
• Notice the
two drops
in their
impressive
revenue
growth to
a over a
half billion
$s, circa
Y2K and
2012:
#5:
4. • Actually many HIS vendors experienced the same dips due to:
– Y2K – after the mad buying rush to replace “legacy” system pre-2000 for
the date change crisis, hospitals then stopped buying for several years.
– MU - the ARRA stimulus program has done the same thing the past few
years, stirring thousands of sales in 2009 to 2012, then far less since:
Two Meditech Revenue Dips
Y2K
MU
5. • Meditech actually has 3 distinct HIS products & client bases:
– Magic – first developed in the 1970s as Meditech’s version of
MUMPS, there were over 700 hospitals using it during it’s
heyday (aka “MIIS”), probably less than 600 today...
– “Client/Server” - the quotes are from their contract, as it’s
merely a Windows front-end to MAGIC – a vastly-improved
GUI, but hardly a true C/S like McKesson’s Paragon. C/S sold
very well during the 90s, with ≈500 clients, since dropping.
– Release 6.x – aka Focus and MAT (Meditech Advanced
Technology), this is the latest & greatest iteration product.
Three Meditech Products
• Still a proprietary data base, but far more
modern than Magic or C/S, it is more of an
“Append” data base than B-trieve like the
older technologies, and easily the most
feature-rich, with over 300 sites & growing.
6. • If Meditech were publically held, we’d recommend the stock:
– They should do well among the mid-sized Siemens clients on
Invision and Medseries4, as Cerner stirs them up with its
promise of “support” for 3-5 years...
Meditech Prospects
- Plus they have those 1,000 clients
currently on Magic & C/S to sell
Release 6 to, with nary an RFP…
• They have one other major development that should help sales:
– Their acquisition of LSS for physician practices was a bit of a
bust due to being a separate, interfaced product & data base.
– They recently completed a integrated physician system within
Release 6 with Practice Mgmt. (Reg, Sched, BL) and an EHR.
– With 5 pilots live and scores of sales, this could make them
the mid-sized equivalent to Epic’s integrated MD/HIS – hot!
7. • This may seem a bit redundant in that we covered McK in the
previous episode on “macro” vendors, but if you’re a mid-sized
hospital looking for an HIS, you have to consider their “Paragon”
of HIS systems with about 300 clients.
- When the decision was made to shut
down Horizon and replace it with Paragon
as their “go-forward” solution, McKesson
put all its eggs in this mid-sized basket.
• Like Meditech with LSS, they also learned a lesson from Epic:
– They built an integrated practice management (reg, sched &
BL) on the same Microsoft SQL data base & Windows OS, to
replace the (poorly) interfaced Practice Partners system,
which they sold along with other MD systems last year to
eMDs. The practice management portion is now live, and
they are now promising an integrated EMR by mid 2017…
8. • Known as Keane for several decades, it’s hard to remember this
new name in HIS systems is actually selling several tried & tested
products as “Optimum,” which has several proven components:
- Full suite of clinicals: EHR, CPOE, LIS, RIS, RX, etc.
- Robust revenue cycle (formerly PatCom), with a
long track record going back to PHS in the 80s.
- Solid ERP suite from “partner” ORMED, who has
since bought small competitor CSS/Healthtech…
• Like Siemens & GE, their parent firm is an international giant
with billions (of Yen) in annual revenue, and their healthcare IT
division includes many pieces beyond a pure HIS, including:
- Long Term Care – in which they are an
industry leader over a thousand clients.
- In pure HIS, they have about 200 clients
on various modules of Optimum.
#5:
9. • It’s been a wild ride since Keane sold to Caritor in 2007, who
then sold to NTT Data in 2010. All 3 parents had much larger
generic IT revenue in multiple industries besides healthcare, so
we’ve been estimating what slice HIS comprised of them below:
• NTT Data should
make some sakes
(strange typo!) of
Optimum to mid-
sized Siemens’
clients on MS4.
• They are good at
selling to existing
clients, like
Ernest Health
putting Optimum
in 4 new
NTT Data Revenue HIS-tory
(Y2K)
Caritor
NTT Data
Keane
10. • In March of 2016, NTT Data shocked the industry by agreeing to
buy Dell’s IT consulting division for $3B - yes, that’s a “B” for
“buying too much”! Turns out Dell is spending $60B to buy EMC,
and needs these few billions to help trim its $43B of debt…
– Dell acquired Perot systems back in 2009 for $3.9B, so they’re
actually losing a little, but EMC is quite an enticing target.
• The odd thing is what this does to NTT Data which will now be
both a “consulting” firm and an HIS vendor. Imagine a scenario
where Dell/Perot consultants issue an RFP for a mid-sized
hospital looking to acquire a new HIS – would they send it to
themselves? And other vendors?? Evaluate other proposals???
• Many HIS vendors have “consulting” divisions that offer
assistance during implementations, interim staffing, technical
assistance, etc., but strategic planning, IT assessments, system
selections and contract negotiations usually require objectivity…
2016 Game Changer!
11. • Founded as Health Management Systems in 1984, HMS was
acquired by VC firm Primus in 2007, who formed HealthTech
Holdings as their parent company, then merged them with EDIS
leader MedHost in 2010. Confused? So am I, but at least now no
one mixes them up with the other “HMS” vendor in NYC…
- HMS grew rapidly by selling to the many hospital
chains also based near Nashville, like Community
Health Systems, with 200 hospitals in 29 states.
• Their forte for these chains is an ERP designed to pool cash
payments from many hospitals into one central bank, while
centralizing AP, purchasing & materials as well - tricky stuff!
- MedHost was a long-term leader in EDIS
systems, and with a slick interface to
HMS, they pose a nice solution to how
EDs are the source of most admissions.
12. • Being privately held, we’ve had to estimate their revenue for
some years between these acquisitions and mergers, the only
time $ figures are made public, but the strong growth of hospital
chains like CHS has given them a solid base for revenue growth:
• Adding
Medhost’s
EDIS
revenue in
2012 gave
them a huge
revenue
jump, but
they’re
down a bit
since…
HMS/Medhost Revenue HIS-tory
HMS
Medhost
13. • Their HIS client base is mostly smaller & mid-sized hospitals that
proprietary chains like CHS tend to acquire; included in the
hospital figures below are ≈370 EDIS clients of all bed sizes.
Medhost Client Base
Acute Care Hospitals Non-acute Care Facilities
14. • The last player in the mid-sized hospital market is a familiar name
but one that has gone through a number of owners & products:
- Starting as Compucare in the 70s, they developed
their Affinity HIS in the 90s, which sold very well.
- Bought by QuadraMed, who tried to build an EHR
& CPOE in the early 2000s, but failed leading to:
- Sale to VC firm Francisco Partners who acquired
CPR from Misys/Per Se (née UltiCare from HDS).
• Francisco then sold QM to the N. Harris division of Constellation
Software, a Canadian firm, who left the name & products alone:
- Affinity – a solid RCM and basic HIS, with
about 100 hospitals still running it.
- QCPR – “QuadraMed’s Computerized
Medical Record,” with about 50 clients
15. • QuadraMed made their revenue figures public for about 25
years, so here’s a chart of how they grew handsomely during the
90s when Affinity was hot and hospitals were buying like crazy to
prepare for the Y2K “Armageddon” (that never happened...)
• Revenue
dipped after
the sale of
Quantim to
Nuance 2012.
• Purchase of
NextGen’s
HIS systems
gives them a
nice client
base to sell
QCPR to…
QuadraMed Revenue HIS-tory
Y2K
Quantim
Sale
16. Next Week
• Our final episode next week covers the remaining HIS vendors,
specializing in the small market (in terms of beds and revenue):
– Their client bases consists of mostly under 100 bed
community hospitals, including CAH (Critical Access
Hospitals) of under 25 beds (with over 1,000 in the US!):
• Evident (CPSI) – leader even before acquiring Healthland
– Plus two new entrants shaking up the HIS field:
• athenahealth – MD giant now in HIS through RazorInsights
• eClinicalWorks – physician practice giant entering HIS…
– And several small hospital players deserving mention…
• With the HIS industry being so wide and deep, we might have
missed something, so if you’d like, have your attorneys contact:
- vciotti@hispros.com eames@hispros.com
- 505.466.4958 413.329.6925